Peptides for therapy and diagnosis of Alzheimer's disease.
about
Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in HumansCopper phenotype in Alzheimer's disease: dissecting the pathwayA resorcinarene for inhibition of Aβ fibrillation.An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice.Rationally designed peptoids modulate aggregation of amyloid-beta 40.Strong inhibition of beta-amyloid peptide aggregation realized by two-steps evolved peptides.L17A/F19A Substitutions Augment the α-Helicity of β-Amyloid Peptide Discordant Segment.Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.Alzheimer's amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity.Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders.Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.β-Hairpin mimics containing a piperidine-pyrrolidine scaffold modulate the β-amyloid aggregation process preserving the monomer species.Minor Structural Variations of Small Molecules Tune Regulatory Activities toward Pathological Factors in Alzheimer's Disease.Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β-Protein Aggregation and Cytotoxicity.One-Pot Synthesis of Thermoresponsive Amyloidogenic Peptide-Polymer Conjugates via Thio-Bromo "Click" Reaction of RAFT Polymers.Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid β-protein aggregation and cytotoxicity.GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals
P2860
Q26765775-3FA5969C-A495-4E9C-B492-787D295DCD93Q28294380-C59D8C3C-E12D-4B22-8EC3-358E44B6D72CQ33583650-B54E7782-E592-4CAD-93A8-E5A6F84051BCQ33626081-10FED73E-F420-47A0-8F4C-C5298145E309Q33918190-6018EC84-12F7-4499-A2D8-C0712D3C1C2FQ35216864-7623F4FB-9B7C-42F6-88B2-2A25BDAB9489Q35996839-152EDD73-2CE2-45B6-AC09-1B4354FF0FB0Q36231741-C6865584-E948-4599-800A-E62E5538A188Q36330092-C1DA1F7D-81BE-43AC-B547-6A1DB448B994Q39148389-2893F8B9-4E06-4DF6-9218-5411179221EEQ41428294-AC73E32B-8886-42F0-BEED-657FB36927A1Q42314973-EF0C7C86-86DA-47C7-8FD6-20CF99D926E9Q46291330-689FC7F4-C920-4620-8282-A79B63D9B88FQ46429161-2C5AFBD1-E6A9-42FC-A0C3-ECFF00300C8DQ47629109-12C9A5A8-8C54-434E-A459-076378C00765Q50199459-90F6D07F-5C2B-4601-AA9E-4A800E94F602Q55006962-C37D1612-C927-4898-8261-8EB5822C8371Q57021945-E2A9B85B-647B-4DCD-8048-29D9E51DC541
P2860
Peptides for therapy and diagnosis of Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Peptides for therapy and diagnosis of Alzheimer's disease.
@ast
Peptides for therapy and diagnosis of Alzheimer's disease.
@en
Peptides for therapy and diagnosis of Alzheimer's disease.
@nl
type
label
Peptides for therapy and diagnosis of Alzheimer's disease.
@ast
Peptides for therapy and diagnosis of Alzheimer's disease.
@en
Peptides for therapy and diagnosis of Alzheimer's disease.
@nl
prefLabel
Peptides for therapy and diagnosis of Alzheimer's disease.
@ast
Peptides for therapy and diagnosis of Alzheimer's disease.
@en
Peptides for therapy and diagnosis of Alzheimer's disease.
@nl
P2860
P1476
Peptides for therapy and diagnosis of Alzheimer's disease.
@en
P2093
Susanne Aileen Funke
P2860
P304
P356
10.2174/138161212799277752
P5008
P577
2012-01-01T00:00:00Z